Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

BASF SE Add to portfolio

DAXX:BAS, Oct 16, 08:37 UTC

Latest DAXX:BAS News

Filter your feed

Apply Filter

Today


Social Chatter

BASF SE (DAXX:BAS) social chatter is higher than usual

BAS
White Biotechnology Market is Booming Worldwide with Growth Rate of 8.9% During 2017-2025 | Top Players; BioAmber, BASF, Codexis, Amyris, Deinove, Evolva, Metabolic Explorer, Novozymes, and Solazyme https://t.co/Ij1QlsaBYN https://t.co/GazAHRtC6L

Yesterday


News

ExxonMobil Catalysts and Licensing LLC and BASF Corporation to Demonstrate the Next Generation of High Performance Selective Solvent to Decrease Sulfur Emissions

BAS

The highly selective properties of the solvent allow refiners and gas processors to increase capacity and lower operating costs in existing equipment. For new treating facilities, the usage of the technology will reduce the size of the equipment and the initial capital investments. When used in a tail gas treating unit in conjunction with a Claus sulfur recovery unit (SRU), the new technology has the capability to achieve greater than 99.99% overall sulfur recovery and very low emissions to cope with future requirements. “Thoroughly tested at BASF’s dedicated pilot plant in Ludwigshafen, Germany, the solvent showed improved H2S selectivity and lower energy consumption than other selective solvents,” said Andreas Northemann, Vice President of BASF Gas Treatment. FLEXSORB SE and SE Plus are registered trademarks of ExxonMobil. For more information on BASF Gas Treating Excellence, visit www.basf.com/oase. ExxonMobil’s cutting-edge proprietary catalysts, gas treating solvents and advantaged process technologies help refineries and petrochemical manufacturers and gas processors increase capacity, lower costs, improve margins, reduce emissions and operate safe, reliable and efficient facilities.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Sunday, October 14


News

Basf (ETR:BAS) PT Set at €101.00 by Barclays – XNewsPress

BAS

Kepler Capital Markets set a €120.00 ($139.53) price target on Basf and gave the stock a buy rating in a research note on Friday, July 27th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and fourteen have given a buy rating to the company. Basf presently has a consensus rating of Buy and an average price target of €95.80 ($111.40). Basf has a 12-month low of €78.97 ($91.83) and a 12-month high of €98.70 ($114.77).

Read Full Details

Topics:
  • Business
  • Financial
News

Kepler Capital Markets Analysts Give Basf (ETR:BAS) a €120.00 Price Target – PressOracle

BARC BAS

Basf (ETR:BAS) has been given a €120.00 ($139.53) price target by equities research analysts at Kepler Capital Markets in a research note issued on Friday, September 28th. Kepler Capital Markets’ price target would indicate a potential upside of 73.86% from the company’s previous close. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and fourteen have issued a buy rating to the company. Basf currently has an average rating of “Buy” and an average target price of €95.80 ($111.40).

Read Full Details

Topics:
  • Business
  • Financial

Saturday, October 13


News

Basf (ETR:BAS) Given a €120.00 Price Target by Kepler Capital Markets Analysts – Fairfield Current

BAS

Basf (ETR:BAS) received a €120.00 ($139.53) price objective from equities research analysts at Kepler Capital Markets in a research report issued to clients and investors on Friday, September 28th. Kepler Capital Markets’ target price suggests a potential upside of 73.86% from the stock’s previous close. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and fourteen have issued a buy rating to the stock. Basf has a fifty-two week low of €78.97 ($91.83) and a fifty-two week high of €98.70 ($114.77).

Read Full Details

Topics:
  • Business
  • Financial
News

Basf (ETR:BAS) Given a €94.00 Price Target by Nord/LB Analysts – Marea Informative

BAS

A number of other equities research analysts have also commented on the company. Commerzbank set a €95.00 ($110.47) price objective on Basf and gave the stock a buy rating in a research report on Wednesday, September 26th. Societe Generale set a €95.00 ($110.47) price objective on Basf and gave the stock a buy rating in a research report on Tuesday, September 25th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and fourteen have issued a buy rating to the stock. Basf has an average rating of Buy and a consensus price target of €95.80 ($111.40).

Read Full Details

Topics:
  • Business
  • Financial

Friday, October 12


News

Basf (BAS) Given a €95.00 Price Target by Societe Generale Analysts – Marea Informative

BAS

Basf (BAS) Given a €95.00 Price Target by Societe Generale Analysts – Marea Informative. Societe Generale set a €95.00 ($110.47) price target on Basf (ETR:BAS) in a research note released on Tuesday, September 25th. Several other research firms have also issued reports on BAS. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and fourteen have given a buy rating to the stock. Shares of BAS stock traded down €0.98 ($1.14) during mid-day trading on Tuesday, hitting €69.02 ($80.26).

Read Full Details

Topics:
  • Business
  • Financial

Thursday, October 11


News

Agricultural Antibacterials - Global Market Opportunities to 2023 featuring BASF, Bayer Cropscience, Dow Agrosciences, FMC Corp, Nippon Soda, and many more - ResearchAndMarkets.com

BAS FMC

Agricultural Antibacterials - Global Market Opportunities to 2023 featuring BASF, Bayer Cropscience, Dow Agrosciences, FMC Corp, Nippon Soda, and many more - ResearchAndMarkets.com. DUBLIN--(BUSINESS WIRE)--The "Global Agricultural Antibacterials Market - Segmented by Type, Crop Type, Forms and Geography- Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering. The Global Agricultural Antibacterials Market was valued at USD 9.73 billion in 2017 and is expected to register a CAGR of 3.9% during the forecast period (2018-2023). Europe is one of the largest regions contributing to the agricultural antibacterials market.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
  • Science
News

UBS Group Analysts Give Basf (BAS) a €80.00 Price Target – Marea Informative

BAS

UBS Group set a €80.00 ($93.02) target price on Basf (ETR:BAS) in a report published on Thursday, October 4th, www.boersen-zeitung.de reports. Kepler Capital Markets set a €120.00 ($139.53) price objective on Basf and gave the company a buy rating in a research note on Friday, June 8th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and fourteen have issued a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of €96.32 ($112.00).

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, October 09


News

$100 Billion Giant BASF Partners With Orange County Skin Care Company To Launch Its New Breakthrough Anti-Aging Peptide

BAS

"This is like Shark Tank times 100!," says AminoGenesis Founder, Ron Cummings, "we were in the right place at the right time and as a result we suddenly have the full support from the world's largest chemical company to assist in our efforts." "On a number of parameters, Replexium® (the name of the new peptide) outperforms other well-known active peptides on the market," said David Herault, R&D Global Director for BASF Beauty Creations. "It is our first solution that addresses all three major facial wrinkles, as well as skin firming, and should prove ideal for high-performance skincare products." Due to limited production of Replexium®, AminoGenesis was able to acquire the entire US supply and quickly get it to market.

Read Full Details

Topics:
  • Business
  • Health
  • Technology
  • Science